$ News

Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio

Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies

Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings

Orgenesis Provides Third Quarter 2024 Business Update

Orgenesis Expands Board with Three New Appointments

Orgenesis Commences Trading on OTCQX® Best Market

Orgenesis commences trading on OTCQX Best Market

12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Orgenesis Announces Reverse Stock Split

Orgenesis announces 1-for-10 reverse stock split to regain Nasdaq compliance

Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia

Orgenesis announces results for study of CD19 CAR-T therapy

Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally

Orgenesis announces JV partnership with Harley Street Healthcare Group

Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024

Orgenesis GAAP EPS of $0.23

Orgenesis Provides Second Quarter 2024 Business Update